SOLAXA
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 May 2026)
What this means for you
This application is over — abandoned 04 May 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97314635
- Mark type
- Word mark
- Filed
- 16 Mar 2022
- Published for opposition
- 31 Jan 2023
- Abandoned
- 04 May 2026
- Attorney of record
- Randy Michels
Goods and services
- Class 005 — Pharmaceuticals: Neuro-regenerative pharmaceutical products for the treatment of nerve injuries
Owner
- Solaxa Inc., Chevy Chase, MD, US
- Solaxa Inc., Chevy Chase, MD, US
Prosecution history
- 04 May 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 May 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 5 GRANTED
- 25 Sept 2025 — SOU EXTENSION 5 FILED
- 11 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2025 — SOU EXTENSION 4 GRANTED
- 05 Feb 2025 — SOU EXTENSION 4 FILED
- 05 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2024 — SOU EXTENSION 3 GRANTED
- 31 Jul 2024 — SOU EXTENSION 3 FILED
- 31 Jul 2024 — SOU TEAS EXTENSION RECEIVED